Key stats
Market capitalization
595.146MCHF
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
49.50
Basic EPS (TTM)
1.00CHF
About BASILEA N
ISIN
CH0011432447
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
basilea.com
CEO
David Veitch
Headquarters
Allschwil
Employees
154
Founded
2000
Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. Its products include Cresemba, Zevtera, Derazantinib, BAL101553, and BAL3833. The company was founded on October 17, 2000 and is headquartered in Allschwil, Switzerland.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0